Font Size
A
A
A

muromonab-CD3 (cont.)

What should I discuss with my health care provider before receiving muromonab-CD3 (Orthoclone OKT3)?

You should not be given this medication if you are allergic to muromonab or mouse proteins, or if you have:

Before receiving muromonab-CD3, tell your doctor if you are allergic to any drugs, or if you have:

If you have any of these conditions, you may need a dose adjustment or special tests to safely receive muromonab-CD3.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether muromonab-CD3 passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How is muromonab-CD3 given (Orthoclone OKT3)?

Muromonab-CD3 is given as an injection through a needle placed into a vein. You will receive this injection just before your transplant and again 4 days afterward. The medicine must be given slowly through an IV infusion, and can take up to 30 minutes to complete.

You may also be given a steroid medication before you receive muromonab-CD3.

Muromonab-CD3 can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. It is important that you not miss any scheduled visits to your doctor after your transplant.

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Identifier Tool

Need help identifying pills and medications?
Use the pill finder tool on RxList.



NIH talks about Ebola on WebMD